Meyer R. Heyman

3.8k total citations · 1 hit paper
22 papers, 2.8k citations indexed

About

Meyer R. Heyman is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Meyer R. Heyman has authored 22 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 6 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Meyer R. Heyman's work include Multiple Myeloma Research and Treatments (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Meyer R. Heyman is often cited by papers focused on Multiple Myeloma Research and Treatments (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Meyer R. Heyman collaborates with scholars based in United States, Canada and Spain. Meyer R. Heyman's co-authors include A.J. Grillo-López, Michael E. Williams, Vinay Jain, Diying Shen, Peter McLaughlin, Ronald Levy, Christine A. White, B.K. Dallaire, Isabelle Bence‐Bruckler and Fernando Cabanillas and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Meyer R. Heyman

21 papers receiving 2.7k citations

Hit Papers

Rituximab chimeric anti-CD20 monoclonal antibody therapy ... 1998 2026 2007 2016 1998 500 1000 1.5k 2.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
    1998 2.2k citations Peter McLaughlin, A.J. Grillo-López et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meyer R. Heyman United States 14 1.4k 1.1k 924 752 699 22 2.8k
Tak Takvorian United States 27 1.5k 1.1× 1.1k 1.0× 899 1.0× 399 0.5× 534 0.8× 58 2.9k
C. Varns United States 9 1.5k 1.0× 986 0.9× 795 0.9× 969 1.3× 572 0.8× 9 2.4k
Rémy Gressin France 26 1.7k 1.2× 1.2k 1.1× 880 1.0× 279 0.4× 561 0.8× 109 2.5k
Diying Shen China 10 1.7k 1.2× 1.2k 1.1× 1.2k 1.3× 1.1k 1.4× 905 1.3× 34 3.0k
Isabelle Bence‐Bruckler Canada 18 2.0k 1.4× 1.5k 1.3× 1.4k 1.5× 995 1.3× 853 1.2× 62 3.5k
Joke W. Baars Netherlands 23 899 0.6× 935 0.8× 507 0.5× 301 0.4× 505 0.7× 52 2.4k
Karim Belhadj France 25 2.3k 1.7× 1.6k 1.4× 779 0.8× 577 0.8× 444 0.6× 101 3.6k
Raymond E. Felgar United States 22 891 0.6× 486 0.4× 536 0.6× 682 0.9× 1.4k 1.9× 38 2.8k
Barry I. Samuels United States 21 1.5k 1.1× 1.3k 1.2× 739 0.8× 149 0.2× 445 0.6× 69 2.7k
Lapo Alinari United States 30 1.7k 1.2× 793 0.7× 491 0.5× 487 0.6× 518 0.7× 115 2.8k

Countries citing papers authored by Meyer R. Heyman

Since Specialization
Citations

This map shows the geographic impact of Meyer R. Heyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meyer R. Heyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meyer R. Heyman more than expected).

Fields of papers citing papers by Meyer R. Heyman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meyer R. Heyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meyer R. Heyman. The network helps show where Meyer R. Heyman may publish in the future.

Co-authorship network of co-authors of Meyer R. Heyman

This figure shows the co-authorship network connecting the top 25 collaborators of Meyer R. Heyman. A scholar is included among the top collaborators of Meyer R. Heyman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meyer R. Heyman. Meyer R. Heyman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Li, et al.. (2014). A Case of IgG2 Heavy Chain Deposition Disease in a Patient with Kappa Positive Plasma Cell Dyscrasia. Case Reports in Nephrology and Dialysis. 5(1). 6–12.
2.
Chadha, Manpreet, et al.. (2008). Acute promyelocytic leukemia after mitoxantrone therapy for multiple sclerosis. Cancer Genetics and Cytogenetics. 182(2). 126–129. 13 indexed citations
3.
Badros, Ashraf, et al.. (2007). Neurotoxicity of bortezomib therapy in multiple myeloma: A single‐center experience and review of the literature. Cancer. 110(5). 1042–1049. 175 indexed citations
4.
Buadi, Francis K., Meyer R. Heyman, Christopher D. Gocke, et al.. (2006). Treatment and outcomes of post‐transplant lymphoproliferative disease: A single institution study. American Journal of Hematology. 82(3). 208–214. 24 indexed citations
5.
Tummala, Mohan K., Leno Thomas, Christopher D. Gocke, Meyer R. Heyman, & Ivana Gojo. (2005). Unusual Leukemia Presentations. Journal of Clinical Oncology. 23(24). 5840–5841. 6 indexed citations
6.
Badros, Ashraf, Olga Goloubeva, Aaron P. Rapoport, et al.. (2005). Phase II Study of G3139, a Bcl-2 Antisense Oligonucleotide, in Combination With Dexamethasone and Thalidomide in Relapsed Multiple Myeloma Patients. Journal of Clinical Oncology. 23(18). 4089–4099. 76 indexed citations
7.
Takebe, Naoko, Xiangfei Cheng, Suhlan Wu, et al.. (2004). Phase I Clinical Trial of the Inosine Monophosphate Dehydrogenase Inhibitor Mycophenolate Mofetil (Cellcept) in Advanced Multiple Myeloma Patients. Clinical Cancer Research. 10(24). 8301–8308. 36 indexed citations
8.
Neschis, David G., et al.. (2002). Coagulopathy as a result of factor V inhibitor after exposure to bovine topical thrombin. Journal of Vascular Surgery. 35(2). 400–402. 27 indexed citations
9.
Abruzzo, Lynne V., et al.. (2001). Retroperitoneal follicular dendritic cell sarcoma presenting as secondary amyloidosis. Surgery. 130(1). 109–111. 16 indexed citations
10.
Gojo, Ivana, Guido Tricot, R. G. Fenton, et al.. (2000). Autologous stem cell transplantation (ASCT) followed by consolidation chemotherapy for multiple myeloma (MM). Blood. 96. 1 indexed citations
11.
McLaughlin, Peter, A.J. Grillo-López, Brian K. Link, et al.. (1998). Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.. Journal of Clinical Oncology. 16(8). 2825–2833. 2153 indexed citations breakdown →
12.
Flowers, John L., Alan Kawarai Lefor, John Steers, et al.. (1996). Laparoscopic Splenectomy in Patients with Hematologic Diseases. Annals of Surgery. 224(1). 19–28. 116 indexed citations
13.
Kingreen, D., Bakul I. Dalal, Meyer R. Heyman, et al.. (1995). Lymphocytosis of large granular lymphocytes in patients with hodgkin's disease. American Journal of Hematology. 50(4). 234–236. 12 indexed citations
14.
Lefor, Alan Kawarai, John L. Flowers, & Meyer R. Heyman. (1993). Laparoscopic staging of Hodgkin's disease. Surgical Oncology. 2(3). 217–220. 24 indexed citations
15.
Heyman, Meyer R.. (1991). Recent advances in biology and treatment of myelodysplasia. Current Opinion in Oncology. 3(1). 44–53. 8 indexed citations
16.
Heyman, Meyer R. & Thersa Sweet. (1990). Thrombotic Thrombocytopenic Purpura Treated With High-Dose Intravenous Gamma Globulin. Southern Medical Journal. 83(12). 1471–1474. 10 indexed citations
17.
Heyman, Meyer R., et al.. (1988). Failure of high‐dose I.V. Gammaglobulin in the treatment of spontaneously acquired factor VIII inhibitors. American Journal of Hematology. 28(3). 191–194. 19 indexed citations
18.
Papadimitriou, John C., Anuradha Chakravarthy, & Meyer R. Heyman. (1988). Pseudo-Gaucher Cells Preceding the Appearance of Immunoblastic Lymphoma. American Journal of Clinical Pathology. 90(4). 454–458. 15 indexed citations
19.
Heyman, Meyer R. & Thomas J. Walsh. (1987). Autoimmune neutropenia and Hodgkin's disease. Cancer. 59(11). 1903–1905. 9 indexed citations
20.
Heyman, Meyer R., et al.. (1987). Case Report: Prolonged Vancomycin-Associated Neutropenia in a Chronic Hemodialysis Patient. The American Journal of the Medical Sciences. 294(2). 110–113. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tak Takvorian Breakdown of academic impact, for papers by C. Varns Breakdown of academic impact, for papers by Rémy Gressin Breakdown of academic impact, for papers by Diying Shen Breakdown of academic impact, for papers by Isabelle Bence‐Bruckler Breakdown of academic impact, for papers by Joke W. Baars Breakdown of academic impact, for papers by Karim Belhadj Breakdown of academic impact, for papers by Raymond E. Felgar Breakdown of academic impact, for papers by Barry I. Samuels Breakdown of academic impact, for papers by Lapo Alinari
Rankless by CCL
2026